Literature DB >> 22180311

The importance of CELF control: molecular and biological roles of the CUG-BP, Elav-like family of RNA-binding proteins.

Twishasri Dasgupta1, Andrea N Ladd.   

Abstract

RNA processing is important for generating protein diversity and modulating levels of protein expression. The CUG-BP, Elav-like family (CELF) of RNA-binding proteins regulate several steps of RNA processing in the nucleus and cytoplasm, including pre-mRNA alternative splicing, C to U RNA editing, deadenylation, mRNA decay, and translation. In vivo, CELF proteins have been shown to play roles in gametogenesis and early embryonic development, heart and skeletal muscle function, and neurosynaptic transmission. Dysregulation of CELF-mediated programs has been implicated in the pathogenesis of human diseases affecting the heart, skeletal muscles, and nervous system.
Copyright © 2011 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22180311      PMCID: PMC3243963          DOI: 10.1002/wrna.107

Source DB:  PubMed          Journal:  Wiley Interdiscip Rev RNA        ISSN: 1757-7004            Impact factor:   9.957


  130 in total

1.  CELF and PTB proteins modulate the inclusion of the β-tropomyosin exon 6B during myogenic differentiation.

Authors:  Alain Sureau; Jérôme Saulière; Alain Expert-Bezançon; Joëlle Marie
Journal:  Exp Cell Res       Date:  2010-09-25       Impact factor: 3.905

2.  Genomic organization and isoform-specific tissue expression of human NAPOR (CUGBP2) as a candidate gene for familial arrhythmogenic right ventricular dysplasia.

Authors:  D Li; L L Bachinski; R Roberts
Journal:  Genomics       Date:  2001-06-15       Impact factor: 5.736

3.  Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy.

Authors:  R S Savkur; A V Philips; T A Cooper
Journal:  Nat Genet       Date:  2001-09       Impact factor: 38.330

4.  Novel role for RNA-binding protein CUGBP2 in mammalian RNA editing. CUGBP2 modulates C to U editing of apolipoprotein B mRNA by interacting with apobec-1 and ACF, the apobec-1 complementation factor.

Authors:  S Anant; J O Henderson; D Mukhopadhyay; N Navaratnam; S Kennedy; J Min; N O Davidson
Journal:  J Biol Chem       Date:  2001-09-27       Impact factor: 5.157

5.  Vegetal localization of the maternal mRNA encoding an EDEN-BP/Bruno-like protein in zebrafish.

Authors:  H Suzuki; S Maegawa; T Nishibu; T Sugiyama; K Yasuda; K Inoue
Journal:  Mech Dev       Date:  2000-05       Impact factor: 1.882

6.  Developmentally-regulated expression of mNapor encoding an apoptosis-induced ELAV-type RNA binding protein.

Authors:  D K Choi; T Ito; F Tsukahara; M Hirai; Y Sakaki
Journal:  Gene       Date:  1999-09-03       Impact factor: 3.688

7.  Alternative splicing dysregulation secondary to skeletal muscle regeneration.

Authors:  James P Orengo; Amanda J Ward; Thomas A Cooper
Journal:  Ann Neurol       Date:  2011-03-11       Impact factor: 10.422

8.  Bruno regulates gurken during Drosophila oogenesis.

Authors:  Paolo Filardo; Anne Ephrussi
Journal:  Mech Dev       Date:  2003-03       Impact factor: 1.882

9.  A strategy to analyze the phenotypic consequences of inhibiting the association of an RNA-binding protein with a specific RNA.

Authors:  Marie Cibois; Carole Gautier-Courteille; Audrey Vallée; Luc Paillard
Journal:  RNA       Date:  2009-11-23       Impact factor: 4.942

10.  Mechanism of the internal ribosome entry site-mediated translation of serine hydroxymethyltransferase 1.

Authors:  Jennifer T Fox; Patrick J Stover
Journal:  J Biol Chem       Date:  2009-09-04       Impact factor: 5.157

View more
  107 in total

1.  The cataract-linked RNA-binding protein Celf1 post-transcriptionally controls the spatiotemporal expression of the key homeodomain transcription factors Pax6 and Prox1 in lens development.

Authors:  Sandeep Aryal; Justine Viet; Bailey A T Weatherbee; Archana D Siddam; Francisco G Hernandez; Carole Gautier-Courteille; Luc Paillard; Salil A Lachke
Journal:  Hum Genet       Date:  2020-06-27       Impact factor: 4.132

Review 2.  Global impact of RNA splicing on transcriptome remodeling in the heart.

Authors:  Chen Gao; Yibin Wang
Journal:  J Zhejiang Univ Sci B       Date:  2012-08       Impact factor: 3.066

Review 3.  Alternative splicing programming of axon formation.

Authors:  Sika Zheng
Journal:  Wiley Interdiscip Rev RNA       Date:  2020-01-10       Impact factor: 9.957

4.  Rbm20-deficient cardiogenesis reveals early disruption of RNA processing and sarcomere remodeling establishing a developmental etiology for dilated cardiomyopathy.

Authors:  Rosanna Beraldi; Xing Li; Almudena Martinez Fernandez; Santiago Reyes; Frank Secreto; Andre Terzic; Timothy M Olson; Timothy J Nelson
Journal:  Hum Mol Genet       Date:  2014-02-28       Impact factor: 6.150

Review 5.  CELFish ways to modulate mRNA decay.

Authors:  Irina Vlasova-St Louis; Alexa M Dickson; Paul R Bohjanen; Carol J Wilusz
Journal:  Biochim Biophys Acta       Date:  2013-01-15

Review 6.  Antisense oligonucleotides: rising stars in eliminating RNA toxicity in myotonic dystrophy.

Authors:  Zhihua Gao; Thomas A Cooper
Journal:  Hum Gene Ther       Date:  2013-01-30       Impact factor: 5.695

7.  Aberrant RNA Splicing in Cancer.

Authors:  Luisa Escobar-Hoyos; Katherine Knorr; Omar Abdel-Wahab
Journal:  Annu Rev Cancer Biol       Date:  2018-11-28

Review 8.  CUG-BP, Elav-like family (CELF)-mediated alternative splicing regulation in the brain during health and disease.

Authors:  Andrea N Ladd
Journal:  Mol Cell Neurosci       Date:  2012-12-14       Impact factor: 4.314

9.  RBFox1-mediated RNA splicing regulates cardiac hypertrophy and heart failure.

Authors:  Chen Gao; Shuxun Ren; Jae-Hyung Lee; Jinsong Qiu; Douglas J Chapski; Christoph D Rau; Yu Zhou; Maha Abdellatif; Astushi Nakano; Thomas M Vondriska; Xinshu Xiao; Xiang-Dong Fu; Jau-Nian Chen; Yibin Wang
Journal:  J Clin Invest       Date:  2015-11-30       Impact factor: 14.808

Review 10.  Roles for RNA-binding proteins in development and disease.

Authors:  Amy E Brinegar; Thomas A Cooper
Journal:  Brain Res       Date:  2016-03-10       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.